- Home
- ADXN vs STRR Comparison
ADXN vs STRR Comparison
Compare ADXN & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- STRR
- Stock Information
- Founded
- ADXN 2002
- STRR 1985
- Country
- ADXN Switzerland
- STRR United States
- Employees
- ADXN N/A
- STRR N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ADXN Health Care
- STRR Health Care
- Exchange
- ADXN Nasdaq
- STRR Nasdaq
- Market Cap
- ADXN 8.1M
- STRR 6.3M
- IPO Year
- ADXN N/A
- STRR N/A
- Fundamental
- Price
- ADXN $7.90
- STRR $2.42
- Analyst Decision
- ADXN Strong Buy
- STRR
- Analyst Count
- ADXN 1
- STRR 0
- Target Price
- ADXN $30.00
- STRR N/A
- AVG Volume (30 Days)
- ADXN 4.6K
- STRR 19.0K
- Earning Date
- ADXN 06-05-2025
- STRR 05-19-2025
- Dividend Yield
- ADXN N/A
- STRR N/A
- EPS Growth
- ADXN N/A
- STRR N/A
- EPS
- ADXN 0.06
- STRR N/A
- Revenue
- ADXN $701,260.00
- STRR $53,359,000.00
- Revenue This Year
- ADXN N/A
- STRR $43.37
- Revenue Next Year
- ADXN N/A
- STRR $23.60
- P/E Ratio
- ADXN $1.05
- STRR N/A
- Revenue Growth
- ADXN N/A
- STRR 16.54
- 52 Week Low
- ADXN $6.51
- STRR $1.72
- 52 Week High
- ADXN $13.27
- STRR $5.35
- Technical
- Relative Strength Index (RSI)
- ADXN 51.90
- STRR 64.50
- Support Level
- ADXN $7.72
- STRR $2.14
- Resistance Level
- ADXN $8.07
- STRR $2.14
- Average True Range (ATR)
- ADXN 0.30
- STRR 0.21
- MACD
- ADXN 0.04
- STRR 0.05
- Stochastic Oscillator
- ADXN 62.50
- STRR 77.53
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.